Hepatitis, Chronic: all 829 studies
Page 4 of 9. Open to participants first (44), then studies with results posted, then the rest; newest registration first within each.
- Evaluation of the Efficacy and Safety of the Fixed-dose Combination Sofosdac® 400mg/60mg in Patients With Chronic Hepatitis C (HCV)CompletedNCT05138523
- Treatment of Chronic Hepatitis C Infection by Ledipasvir/Sofosbuvir in Naïve ChildrenCompletedNCT05091008Phase 2
- A Single and Repeated Dose Escalation of RBD1016 in Subjects with Chronic Hepatitis B Virus (HBV) InfectionCompletedNCT05017116Phase 1
- A Study of ALG-020572 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single Doses in Healthy Volunteers and Multiple Doses in CHB SubjectsTerminatedNCT05001022Phase 1
- The Efficacy and Safety of 12-week SOF/VEL Regimen Combined With Prophylactic Use of TAF for Treatment-naïve Genotype 1-6 HCV/HBV Co-infection Adult Patients With or Without Compensated Cirrhosis in ChinaStatus unknownNCT04997564Phase 4
- Effort to Narrow the Gap Between in Accordance With Guidelines and Consent to Treat CHB Population in East of ChinaStatus unknownNCT04980664Not applicable
- A 2 PART STUDY EVALUATING EDP-721 IN HEALTHY SUBJECTS AND EDP-721 IN COMBINATION WITH EDP-514 IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION.TerminatedNCT04971512Phase 1
- Effectiveness and Safety of Direct-Acting Antiviral Agents for the Treatment of Chronic Hepatitis CStatus unknownNCT04952207
- Regression of Liver Fibrosis by Tenofovir Alafenamide (TAF)Active, not recruitingNCT04939441Phase 4
- A Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis BCompletedNCT04846491Phase 3
- COIN-B: COntrolled Interruption of Nucleos(t)Ide Analogue Treatment in Chronic Hepatitis B InfectionsActive, not recruitingNCT04779970Not applicable
- Safety, Tolerability, and Pharmacokinetics of AB-836 in Healthy Subjects and Subjects With Chronic HBV InfectionTerminatedNCT04775797Phase 1
- Evaluation of Liver Fibrosis With 2D-Shear Wave ElastographyCompletedNCT04759521
- Spirulina (FEM-102) Supplement to Chronic Hepatitis B PatientsCompletedNCT04718831Not applicable
- Combined Ribavirin With Sofosbuvir/Velpatasvir/Voxilaprevir in Retreatment of Chronic Hepatitis C Non-respondersCompletedNCT04695769Phase 4
- Prevalence of Occult Hepatitis B Virus Infection（OBI） in Subjects With Chronic Hepatitis B（CHB） Family HistoryStatus unknownNCT04672915
- Study of Entecavir for Reducing the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B PatientsStatus unknownNCT04646928
- LDT Combined With TDF to Improve EGFR Decreasing in Patients With Chronic Hepatitis B Treated With TDFStatus unknownNCT04643990
- Activity of NCO-48 Fumarate in Treatment-Naive Adults With Chronic Hepatitis BCompletedNCT04629976Phase 1
- Clinical Trials to Compare the Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 DiabetesStatus unknownNCT04584242Phase 4
- Study of Oral Glecaprevir/Pibrentasvir Tablets in Participants Aged 12 Years or Older With Chronic Hepatitis C to Assess Sustained Virological ResponseCompletedNCT04577482
- Study on Antiviral Therapy for HBeAg-positive Chronic Hepatitis B Patients Aged 1-16 YearsStatus unknownNCT04565262Phase 4
- Pradefovir Treatment for the Patients With Chronic Hepatitis B Virus Infections: a Phase3 StudyStatus unknownNCT04543565Phase 3
- Clinical Trial to Evaluate the Efficacy and Safety of TenofoBell® Tablet in Chronic Hepatitis B PatientsCompletedNCT04539652Phase 4
- A Cross-sectional Study for Renal Function of Patients With Chronic Hepatitis B in ChinaStatus unknownNCT04538651
- Plasma Purification and Chronic Hepatitis BStatus unknownNCT04518553Not applicable
- Efficacy and Safety of TAF in Pregnant Women With Chronic Hepatitis B InfectionStatus unknownNCT04507607Early Phase 1
- A Study of ALG-010133 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Healthy Volunteers and CHB SubjectsTerminatedNCT04485663Phase 1
- A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of Oral HRS5091 in Healthy Subjects and Chronic Hepatitis B PatientsStatus unknownNCT04480294Phase 1
- A Phase II Study of Subcutaneously Injected PD-L1 Antibody ASC22 in Chronic Hepatitis B PatientsCompletedNCT04465890Phase 2
- Safety, Tolerability, Pharmacokinetics(PK), Pharmacodynamics(PD) and Food Effect of HRS9950 in Healthy and CHB SubjectsCompletedNCT04464733Phase 1
- Sofosbuvir Plus Daclatasvir With or Without Ribavirin and Chronic HCV Genotype (GT) 4CompletedNCT04387526Phase 2/3
- Effects of Direct-acting Antiviral Agents on HCV Cognitive Function, and Depression in HCV Related Cirrhosis: A Prospective Clinical TrialCompletedNCT04330508
- Therapeutic Hepatitis C Virus VaccineStatus unknownNCT04318379Phase 1
- A Cohort Study on Long-term Clinical Outcomes of Antiviral Therapy in Patients With Chronic Hepatitis B and CirrhosisStatus unknownNCT04301908
- An Observational Cohort Study of Clinical Outcomes After Antiviral Treatment of Chronic Hepatitis CStatus unknownNCT04301882
- Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Sofosbuvir in Treatment-naïve Patients With Chronic Hepatitis C Genotype 1CompletedNCT04246723Phase 2
- Metabolic Changes in Chronic HCV Patients Receiving DAASStatus unknownNCT04211844
- Hepatitis C Elimination in the NetherlandsStatus unknownNCT04208035
- The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC74647 in HCV-infected SubjectsCompletedNCT04201275Phase 1
- Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Chronic Hepatitis bStatus unknownNCT04195074Not applicable
- A Study of the Effectiveness and Clinical Practice Use of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Genotypes 1 to 6 in Russian FederationCompletedNCT04189627
- Metformin as Add-on to the Standard Therapy in Patients With Chronic Hepatitis BCompletedNCT04182321Not applicable
- A Study of TQ-A3334 Combined With Entecavir in the Treatment of Chronic Hepatitis BStatus unknownNCT04180150Phase 2
- Study the Content of the HBV DNA in Liver Biopsy in the Patients Chronic Hepatitis DeltaStatus unknownNCT04170452
- Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated CirrhosisStatus unknownNCT04160897
- An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Tenofovir in Naive Patients With Chronic Hepatitis bStatus unknownNCT04157699Phase 2
- An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Entecavir or Tenofovir in Patients With Chronic Hepatitis b Who Have Received Nucleoside (Acid) TherapyStatus unknownNCT04157257Phase 2
- Effect and Safety of Propofol Fumarate for Mother-to-child Blocking of Hepatitis BStatus unknownNCT04135235
- Observational Cohort Study of Clinical Outcomes After Antiviral Therapy for Chronic Hepatitis CStatus unknownNCT04071353
- Maintaining Antiviral Efficacy After Switching to Generic Entecavir 1 mg for Chronic Hepatitis BStatus unknownNCT04069858Phase 4
- Correlation Between Virus and Biochemical Characteristics and Liver Histological Damage in Untreated Chronic HBV InfectionCompletedNCT04032275
- Cohort Study of Clinical Outcomes in Chronic HBV Infection Patients With Low HBsAg Under Unplanned InterventionStatus unknownNCT04030039
- Cohort Study of Efficacy and Safety of Interferon Intermittent Treatment of Chronic Hepatitis BCompletedNCT04028856
- KW-136 With Sofosbuvir for Chinese Adults With Chronic Hepatitis CCompletedNCT03995485Phase 3
- Enhancing Access to Care for Chronic Hepatitis C Infected Populations in Hong KongActive, not recruitingNCT03993925
- Glecaprevir/Pibrentasvir Real-world Study in ChinaStatus unknownNCT03941821
- Frequency of Anxiety and Depression in Chronic Hepatitis C Patients Recieving Direct-Acting Antiviral AgentsStatus unknownNCT03894696
- Hepatocyte-specific Versus Extracellular Contrast Agents for Liver MRI: Prospective, Intra-individual Comparison of Diagnostic Performance for Hepatocellular CarcinomaStatus unknownNCT03892681Not applicable
- Real-world Effectiveness and Safety of Treatment With DAAs in Patients With CHC(Chronic Hepatitis C)Status unknownNCT03887637
- Real World Evidence of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C in the Russian FederationCompletedNCT03868163
- A Study of GC1102(Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B PatientsStatus unknownNCT03801798Phase 2
- The Optimizing Treatment of Peginterferon Alpha in Chronic Hepatitis B Patients With Low Level HBsAgStatus unknownNCT03801538Phase 4
- Renoprotective Effects of Telbivudine in Chronic Hepatitis BCompletedNCT03778567Phase 4
- Prediction System of Clinical Endpoint Events for Chronic Hepatitis B PatientsActive, not recruitingNCT03777969
- A Study to Investigate the Safety, Efficacy and PK of Multiple Doses of QL-007 in Chronic Hepatitis B Patients in CHINAStatus unknownNCT03770624Phase 1
- Effectiveness of TAF in Reducing Clinical Events in CHB Patients Beyond Treatment Indications by Current GuidelinesActive, not recruitingNCT03753074Phase 4
- TAF Real World Study for Universal EffectivenessStatus unknownNCT03752658
- An Observational Study of Maviret (Glecaprevir/Pibrentasvir) for Korean Chronic Hepatitis C Genotypes 1 to 6 Patients According to the Standard for Re-examination of New DrugsCompletedNCT03740230
- IL-35+Breg/Il-35 Effect on T Cell Immune in Patients With CHBCompletedNCT03734783
- Optimal Treatment for Poor Efficacy of Entecavir in Chronic Hepatitis B PatientsStatus unknownNCT03733652Not applicable
- Grazoprevir/Elbasvir for Genotype 1b Chronic Hepatitis C After Liver or Kidney TransplantationTerminatedNCT03723824Phase 4
- A Study of ABI-H2158 in Healthy Volunteers and Patients With Chronic Hepatitis BCompletedNCT03714152Phase 1
- Study to Determine the Hepatitis C Virus Infection Prevalence Among Patients Attended Primarily for VasculitisCompletedNCT03693586
- Terminator 2 RegisterStatus unknownNCT03643172
- The Safety, Antiviral Activity, and Pharmacokinetics of Morphothiadine Mesilate CapsulesCompletedNCT03638076Phase 2
- Changes in Liver Fibrosis, Lipid Profile and Insulin Resistance in HCV Patients Who Received Antiviral TherapyCompletedNCT03612973Not applicable
- Tenofovir Combination or Mono-therapy for MDR CHBStatus unknownNCT03597633
- Study on Gut Microbiota in Chronic HBV Infected PatientsStatus unknownNCT03587467
- APG-1387 Study of Safety, Tolerability ,PK/PD in Patients With Chronic Hepatitis BCompletedNCT03585322Phase 1
- Hepatitis B Immune Globulin (HBIg) to Restore Immune Control in People With Chronic Hepatitis BWithdrawnNCT03575208Phase 2
- Treatment Efficacy and Safety of TDF-TAF Switch Study in South KoreaStatus unknownNCT03559790
- Observational Study on Pregnant Women With Chronic Hepatitis B and Their InfantsStatus unknownNCT03539016
- "Real Life" Evaluation of Efficacy and Safety of Direct Antiviral Agents (DAAs) for the Treatment of Hepatitis C Virus in EgyptStatus unknownNCT03510637
- Study of Daclatasvir-based Therapy in Chinese Participants With Chronic Hepatitis C (CHC)TerminatedNCT03500562
- Statins in Chronic Hepatitis C Patients Receiving Sofosbuvir/Daclatasvir CombinationCompletedNCT03490097Phase 2/3
- Management of Patients With Hepatitis C in a Public Health Care Setting: The Punjab ModelStatus unknownNCT03488485Not applicable
- Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Daclatasvir in Treatment-Naїve Patients With Chronic Hepatitis C Genotype 1bCompletedNCT03485846Phase 2
- Re-treatment of HCV Following DAA FailureTerminatedNCT03483987Not applicable
- DAA Therapy in Pediatric Patients With Chronic Hepatitis CStatus unknownNCT03481036Not applicable
- Study on Effect of Intestinal Microbiota Transplantation in Chronic Hepatitis BStatus unknownNCT03429439Not applicable
- HBsAb Response After HBV Vaccination in Chronic Hepatitis B Patients Who Have Lost HBsAgStatus unknownNCT03405597Phase 3
- Impact of Chlordecone on Active Chronic HepatitisCompletedNCT03373396Not applicable
- Improvement of Hard Endpoint in Chronic Hepatitis B Patients Treated With Antiviral TherapyStatus unknownNCT03366571
- A Real-World Study of Pegylated Interferon In Nucleoside-treated Patients With Chronic Hepatitis BStatus unknownNCT03357822Phase 4
- Change of Renal Function and Bone Mineral Density in CHB Patients Switch From TDF to TAF vs. Maintaining TDFCompletedNCT03356834Phase 4
- Magnesium Isoglycyrrhizinate Followed by Diammonium Glycyrrhizinate and Combined With Entecavir in Chronic Hepatitis BStatus unknownNCT03349008Phase 4
- Side Effects After Direct-acting Antiviral TreatmentCompletedNCT03346941
- Sequential/Combination Therapy in Nucleoside or Nucleotide Analogue (NA)-Suppressed Chronic Hepatitis B PatientsStatus unknownNCT03332329Phase 4
- Quality of Life and Health Utility of Patients With CHB InfectionsCompletedNCT03329820